ALLMedicine™ Acetylcholine Receptor Antibody Center
Research & Reviews 235 results
https://doi.org/10.1159/000510714
Neuroimmunomodulation Huang P, He XY et. al.
Feb 3rd, 2021 - The aim of the study was to investigate the expression and significance of microRNA-126, microRNA-21, FOXP3mRNA, acetylcholine receptor antibody (AChR-Ab), and interleukin 6 (IL-6) in peripheral blood of patients with myasthenia gravis (MG). From ...
https://doi.org/10.1016/j.jocn.2020.11.017
Journal of Clinical Neuroscience : Official Journal of Th... Yi M, Zhang LJ et. al.
Jan 22nd, 2021 - This study aims to explore the serum levels of IL-27 and the percentages of IL-27-producing cells in MG patients with positive acetylcholine receptor antibody (AChR-MG). A total of 17 AChR-MG patients and 22 sex- and age- matched healthy controls ...
https://doi.org/10.1002/ana.26018
Annals of Neurology; Koay S, Vichayanrat E et. al.
Jan 13th, 2021 - The objective of this study was to evaluate patients with ganglionic acetylcholine receptor antibody (gAChR-Ab) positive autoimmune autonomic ganglionopathy using a multimodal testing protocol to characterize their full clinical phenotype and expl...
https://doi.org/10.1002/mus.27167
Muscle & Nerve; Kushlaf H
Jan 12th, 2021 - Immune profiling beyond antibodies in double seronegative and acetylcholine receptor antibody positive myasthenia gravis: What do we learn?|2021|Kushlaf H,|
https://doi.org/10.1159/000512077
European Neurology; Abuzinadah AR, Alanazy MH et. al.
Dec 15th, 2020 - The aim of the study was to estimate the exacerbation incidence rate (IR) in acetylcholine receptor antibody (AChR)-positive generalized myasthenia gravis (MG) and its predictors. The primary outcome in this retrospective study was to estimate mod...
Clinicaltrials.gov 235 results
https://doi.org/10.1159/000510714
Neuroimmunomodulation Huang P, He XY et. al.
Feb 3rd, 2021 - The aim of the study was to investigate the expression and significance of microRNA-126, microRNA-21, FOXP3mRNA, acetylcholine receptor antibody (AChR-Ab), and interleukin 6 (IL-6) in peripheral blood of patients with myasthenia gravis (MG). From ...
https://doi.org/10.1016/j.jocn.2020.11.017
Journal of Clinical Neuroscience : Official Journal of Th... Yi M, Zhang LJ et. al.
Jan 22nd, 2021 - This study aims to explore the serum levels of IL-27 and the percentages of IL-27-producing cells in MG patients with positive acetylcholine receptor antibody (AChR-MG). A total of 17 AChR-MG patients and 22 sex- and age- matched healthy controls ...
https://doi.org/10.1002/ana.26018
Annals of Neurology; Koay S, Vichayanrat E et. al.
Jan 13th, 2021 - The objective of this study was to evaluate patients with ganglionic acetylcholine receptor antibody (gAChR-Ab) positive autoimmune autonomic ganglionopathy using a multimodal testing protocol to characterize their full clinical phenotype and expl...
https://doi.org/10.1002/mus.27167
Muscle & Nerve; Kushlaf H
Jan 12th, 2021 - Immune profiling beyond antibodies in double seronegative and acetylcholine receptor antibody positive myasthenia gravis: What do we learn?|2021|Kushlaf H,|
https://doi.org/10.1159/000512077
European Neurology; Abuzinadah AR, Alanazy MH et. al.
Dec 15th, 2020 - The aim of the study was to estimate the exacerbation incidence rate (IR) in acetylcholine receptor antibody (AChR)-positive generalized myasthenia gravis (MG) and its predictors. The primary outcome in this retrospective study was to estimate mod...
News 2 results
https://www.mdedge.com/clinicalneurologynews/article/210310/neuromuscular-disorders/placebo-response-negative-rituximab/page/0/1?channel=39313
Oct 17th, 2019 - Suggestions from the data The post hoc subgroup analysis should be interpreted with caution, and the study does not provide firm conclusions, Dr. Nowak noted.
https://www.mdedge.com/ccjm/article/92699/myasthenia-gravis-therapy-immunoadsorbent-may-eliminate-need-plasma-products
Abstract This in vitro study assessed the effectiveness of a new immunoadsorbent (Asahi IM-TR 350) in removing anti-acetylcholine receptor antibody from plasma with minimal loss of albumin. Plasma procured from a myasthenia gravis patient undergoi.
